In bladder cancer, SNHG3 regulates c-MYC to stabilize BMI1 mRNA, highlighting its role in tumorigenesis and proposing the SNHG3/c-MYC/BMI1 axis as a novel therapeutic target [34]. Here, BMI1 is linked to urinary bladder cancer.